The generation of an ADA response has a range of potential consequences for the patient, from no clinical effect to reduced therapeutic efficacy, injection/infusion site reactions and rare but severe adverse events such as anaphylaxis (Smith et al., 2016; Strand et al., 2021). Here, ADA is linked to anaphylaxis.